Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Squire

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Human Molecular Genetics|February 1, 2006
A role for Brca1 in chromosome end maintenanceJ Peter McPherson, M Prakash Hande, Anuradha Poonepalli, et al.
Cancers|November 12, 2013
Automated Quantitative Analysis of p53, Cyclin D1, Ki67 and pERK Expression in Breast Carcinoma Does Not Differ from Expert Pathologist Scoring and Correlates with Clinico-Pathological CharacteristicsJamaica D Cass, Sonal Varma, Andrew G Day, et al.
BMC Cancer|March 21, 2012
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancerAlexandria M Haslehurst, Madhuri Koti, Moyez Dharsee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 5, 2013
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular PathologyNeal I Lindeman, Philip T Cagle, Mary Beth Beasley, et al.
Archives of Pathology & Laboratory Medicine|April 5, 2013
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular PathologyNeal I Lindeman, Philip T Cagle, Mary Beth Beasley, et al.
Genes & Development|May 8, 2004
Collaboration of Brca1 and Chk2 in tumorigenesisJohn Peter McPherson, Bénédicte Lemmers, Atsushi Hirao, et al.
The EMBO Journal|September 3, 2004
Lats2/Kpm is required for embryonic development, proliferation control and genomic integrityJohn Peter McPherson, Laura Tamblyn, Andrew Elia, et al.
Oncology Letters|April 30, 2017
Centrosome amplification in chondrosarcomas: A primary cell culture and cryopreserved tumor sample studyCarla Aparecida Pinheiro, Iberê Cauduro Soares, Valter Penna, et al.
Human Molecular Genetics|May 23, 2002
Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann syndromeRosanna Weksberg, Cheryl Shuman, Oana Caluseriu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancerHumberto Lara-Guerra, Thomas K Waddell, Maria A Salvarrey, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Human Molecular Genetics|February 1, 2006
A role for Brca1 in chromosome end maintenanceJ Peter McPherson, M Prakash Hande, Anuradha Poonepalli, et al.
Cancers|November 12, 2013
Automated Quantitative Analysis of p53, Cyclin D1, Ki67 and pERK Expression in Breast Carcinoma Does Not Differ from Expert Pathologist Scoring and Correlates with Clinico-Pathological CharacteristicsJamaica D Cass, Sonal Varma, Andrew G Day, et al.
BMC Cancer|March 21, 2012
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancerAlexandria M Haslehurst, Madhuri Koti, Moyez Dharsee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 5, 2013
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular PathologyNeal I Lindeman, Philip T Cagle, Mary Beth Beasley, et al.
Archives of Pathology & Laboratory Medicine|April 5, 2013
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular PathologyNeal I Lindeman, Philip T Cagle, Mary Beth Beasley, et al.
Genes & Development|May 8, 2004
Collaboration of Brca1 and Chk2 in tumorigenesisJohn Peter McPherson, Bénédicte Lemmers, Atsushi Hirao, et al.
The EMBO Journal|September 3, 2004
Lats2/Kpm is required for embryonic development, proliferation control and genomic integrityJohn Peter McPherson, Laura Tamblyn, Andrew Elia, et al.
Oncology Letters|April 30, 2017
Centrosome amplification in chondrosarcomas: A primary cell culture and cryopreserved tumor sample studyCarla Aparecida Pinheiro, Iberê Cauduro Soares, Valter Penna, et al.
Human Molecular Genetics|May 23, 2002
Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann syndromeRosanna Weksberg, Cheryl Shuman, Oana Caluseriu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Phase II study of preoperative gefitinib in clinical stage I non-small-cell lung cancerHumberto Lara-Guerra, Thomas K Waddell, Maria A Salvarrey, et al.
Pageof 4